Cargando…
Cisplatin chemotherapy-induced miRNA-210 signaling inhibits hepatocellular carcinoma cell growth
BACKGROUND: Chemotherapy has improved the survival of hepatocellular carcinoma (HCC) patients, but the underlying mechanisms are still not fully understood. MicroRNAs (miRNAs) are critical regulators in carcinogenesis and involved in response to cancer therapy. However, the correlation between miRNA...
Autores principales: | Yu, Huan, Shi, Guangyue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799276/ https://www.ncbi.nlm.nih.gov/pubmed/35116795 http://dx.doi.org/10.21037/tcr.2019.03.26 |
Ejemplares similares
-
MiR-210 inhibits NF-κB signaling pathway by targeting DR6 in osteoarthritis
por: Zhang, Dawei, et al.
Publicado: (2015) -
The role of miRNA-210 in pre-eclampsia development
por: Jaszczuk, Ilona, et al.
Publicado: (2022) -
Upregulation of the miRNA-155, miRNA-210, and miRNA-20b in psoriasis
patients and their relation to IL-17
por: El-Komy, Mohamed, et al.
Publicado: (2020) -
Inhibition of miRNA-210 reverses nicotine-induced brain hypoxic-ischemic injury in neonatal rats
por: Wang, Lei, et al.
Publicado: (2017) -
Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma
por: Osugi, Jun, et al.
Publicado: (2015)